These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 24983928)
21. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462 [TBL] [Abstract][Full Text] [Related]
22. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434 [TBL] [Abstract][Full Text] [Related]
23. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells. Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164 [TBL] [Abstract][Full Text] [Related]
24. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy. Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590 [TBL] [Abstract][Full Text] [Related]
25. Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma. Li Y; Zheng X; Gong M; Zhang J Oncotarget; 2016 Nov; 7(48):79401-79407. PubMed ID: 27765902 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide. Gao H; Zhang S; Yang Z; Cao S; Jiang X; Pang Z Int J Pharm; 2014 May; 466(1-2):8-17. PubMed ID: 24607217 [TBL] [Abstract][Full Text] [Related]
27. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Ren J; Shen S; Wang D; Xi Z; Guo L; Pang Z; Qian Y; Sun X; Jiang X Biomaterials; 2012 Apr; 33(11):3324-33. PubMed ID: 22281423 [TBL] [Abstract][Full Text] [Related]
28. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis. Huang S; Shao K; Liu Y; Kuang Y; Li J; An S; Guo Y; Ma H; Jiang C ACS Nano; 2013 Mar; 7(3):2860-71. PubMed ID: 23451830 [TBL] [Abstract][Full Text] [Related]
29. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting. Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728 [TBL] [Abstract][Full Text] [Related]
30. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033 [TBL] [Abstract][Full Text] [Related]
31. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma. Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282 [TBL] [Abstract][Full Text] [Related]
32. Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis. Wang B; Lv L; Wang Z; Zhao Y; Wu L; Fang X; Xu Q; Xin H Biomaterials; 2014 Jul; 35(22):5897-907. PubMed ID: 24743033 [TBL] [Abstract][Full Text] [Related]
33. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677 [TBL] [Abstract][Full Text] [Related]
34. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas. Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093 [TBL] [Abstract][Full Text] [Related]
35. Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. Gao H; Yang Z; Zhang S; Pang Z; Liu Q; Jiang X Acta Biomater; 2014 Feb; 10(2):858-67. PubMed ID: 24239900 [TBL] [Abstract][Full Text] [Related]
36. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles. Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302 [TBL] [Abstract][Full Text] [Related]
37. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB. Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553 [TBL] [Abstract][Full Text] [Related]
38. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel. Hu Q; Gao X; Gu G; Kang T; Tu Y; Liu Z; Song Q; Yao L; Pang Z; Jiang X; Chen H; Chen J Biomaterials; 2013 Jul; 34(22):5640-50. PubMed ID: 23639530 [TBL] [Abstract][Full Text] [Related]
39. Enhanced blood-brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system. Yao H; Wang K; Wang Y; Wang S; Li J; Lou J; Ye L; Yan X; Lu W; Huang R Biomaterials; 2015 Jan; 37():345-52. PubMed ID: 25453963 [TBL] [Abstract][Full Text] [Related]
40. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas. Kang T; Gao X; Hu Q; Jiang D; Feng X; Zhang X; Song Q; Yao L; Huang M; Jiang X; Pang Z; Chen H; Chen J Biomaterials; 2014 May; 35(14):4319-32. PubMed ID: 24565520 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]